Publication for DCN and FBLN1

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	DCN	decorin	1634			[link]
hsa	FBLN1	fibulin 1	2192

Pubmed ID	Priority	Text
19652764	0.97	FBLN1 (0.5 +- 0.4 vs. 6.1 +- 2.3 fold, p = 0.003) and of DCN (2.5 +- 1.0 vs. 8.5 +- 4.7 fold, p = 0.04) in AAD compared to MS and control samples.
	0.91	FBLN1 (0.5 +- 0.4 vs. 6.1 +- 2.3 fold, p = 0.003) and of DCN (2.5 +- 1.0 vs. 8.5 +- 4.7 fold, p = 0.04) in AAD compared to MS and control samples.
	0.89	decorin, fibulin-1, and others like HMGA2 may prove their role and how they may develop the symptoms of AAD.
	0.85	fibulin-1 (FBLN1), fibulin-2 (FBLN2), decorin (DCN) and microfibrillar associated protein 5 (MFAP5)), which were differentially expressed in all AAD patients included in the analysis (Fig. 2).
	0.72	fibulin-1 and/or of decorin in AAD patients could be an alternative molecular mechanism:opposed to a mutation in fibrillin-1 as seen in patients suffering from Marfan syndrome:leading to the same or similar phenotype.
19145252	0.97	fibulin 1 (FBLN1), decorin (DCN), and collagen type XVIII (COL18A1).
26666363	0.96	decorin, nidogen-1, biglycan, fibulin-1 and tenascins) are also present in the urothelium, but their role in the modulation of tissue functionality has not been clarified.
21804603	0.95	DCN, FHL1 and SPARC showed expression throughout the stroma, and FBLN and NKTR showed expression in few cells dispersed through the stroma (Figure 6; Supplementary Figure 4).
	0.74	FBLN1, FN, OGN, PARVA, ZEB1, CAV1, CFH, S100A6 DCN and FHL1) were localized to the stroma only.
	0.68	FBLN, FN, OGN, PARVA, CAV1, STC1, DCN and FHL1.
	0.55	DCN, FBLN1, FHL1, FN, NKTR, OGN, PARVA, S100A6, SPARC, STC1 and ZEB1 proteins showed specific and varied expression patterns in fetal human prostate and in prostate cancer.
22719844	0.95	DCN and FBLN1 adds prognostic value for near-term events (<2.5 years) for both lymph node-positive and lymph node-negative patients.
	0.87	DCN and FBLN1, and the other containing LAMA2, add substantial prognostic value to the proliferation signal and to clinical measures.
26723257	0.92	decorin, and the elastin-associated proteins fibulin-1 and fibulin-5, while biglycan was significantly decreased with the reduction in versican (Fig. 3).
32033496	0.72	DCN; MFAP4 and 5; FBN2; and FBLN1, 2, and 5.